These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors. Zhao MY; Yin Y; Yu XW; Sangani CB; Wang SF; Lu AM; Yang LF; Lv PC; Jiang MG; Zhu HL Bioorg Med Chem; 2015 Jan; 23(1):46-54. PubMed ID: 25496804 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF Mohassab AM; Hassan HA; Abdelhamid D; Gouda AM; Youssif BGM; Tateishi H; Fujita M; Otsuka M; Abdel-Aziz M Bioorg Chem; 2021 Jan; 106():104510. PubMed ID: 33279248 [TBL] [Abstract][Full Text] [Related]
9. Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking. Ammar UM; Abdel-Maksoud MS; Mersal KI; Ali EMH; Yoo KH; Choi HS; Lee JK; Cha SY; Oh CH Bioorg Med Chem Lett; 2020 Oct; 30(20):127478. PubMed ID: 32781217 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF Ali EMH; El-Telbany RFA; Abdel-Maksoud MS; Ammar UM; Mersal KI; Zaraei SO; El-Gamal MI; Choi SI; Lee KT; Kim HK; Lee KH; Oh CH Eur J Med Chem; 2021 Apr; 215():113277. PubMed ID: 33601311 [TBL] [Abstract][Full Text] [Related]
11. Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening. Ammar UM; Abdel-Maksoud MS; Ali EMH; Mersal KI; Ho Yoo K; Oh CH Bioorg Chem; 2020 Jul; 100():103967. PubMed ID: 32470760 [TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics, MMGBSA, and docking studies of natural products conjugated to tumor-targeted peptide for targeting BRAF V600E and MERTK receptors. Lambo DJ; Lebedenko CG; McCallum PA; Banerjee IA Mol Divers; 2023 Feb; 27(1):389-423. PubMed ID: 35505173 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives. Abdel-Maksoud MS; Kim MR; El-Gamal MI; Gamal El-Din MM; Tae J; Choi HS; Lee KT; Yoo KH; Oh CH Eur J Med Chem; 2015 May; 95():453-63. PubMed ID: 25841200 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAF Alshammari MB; Aly AA; Youssif BGM; Bräse S; Ahmad A; Brown AB; Ibrahim MAA; Mohamed AH Front Chem; 2022; 10():1076383. PubMed ID: 36578355 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis-Pyrazoline Derivatives as Dual EGFR/BRAF Al-Wahaibi LH; Abou-Zied HA; Beshr EAM; Youssif BGM; Hayallah AM; Abdel-Aziz M Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240450 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities. El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484 [TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF Ali EMH; Abdel-Maksoud MS; Ammar UM; Mersal KI; Ho Yoo K; Jooryeong P; Oh CH Bioorg Chem; 2021 Jan; 106():104508. PubMed ID: 33280830 [TBL] [Abstract][Full Text] [Related]
19. Discovery of New Imidazo[2,1- Abdel-Maksoud MS; El-Gamal MI; Lee BS; Gamal El-Din MM; Jeon HR; Kwon D; Ammar UM; Mersal KI; Ali EMH; Lee KT; Yoo KH; Han DK; Lee JK; Kim G; Choi HS; Kwon YJ; Lee KH; Oh CH J Med Chem; 2021 May; 64(10):6877-6901. PubMed ID: 33999621 [TBL] [Abstract][Full Text] [Related]
20. New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity. Sabry MA; Ghaly MA; Maarouf AR; El-Subbagh HI Eur J Med Chem; 2022 Nov; 241():114661. PubMed ID: 35964425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]